John W. Kozarich is Director at LIGAND PHARMACEUTICALS INC (LGND). They have made 33 open-market trades across 4 companies since 2007, most recently 2026-06-05.
CIK 0001223000
13 open-market purchases totalling $392K since 2007, against 20 sales. Across 12 scored buys the stock is down 3.7% at ninety days, and 4.7 points behind the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| LGND | 42,622 | $12.6M |
| QLTI | 57,000 | $1.5M |
| NTEC | 151,761 | $1.5M |
| RTRX | 29,000 | $703K |
| LGNDD | 27,098 | — |
| Total | $16.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-09 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 8% | 25% | 17% |
| Avg Move | -4.3% | -0.9% | -3.7% |
| Alpha | +0.6% | -1.4% | -4.7% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LGND | SELL · 10b5-1 | 2026-05-01 | 2026-05-14 | $225.14 | $563K | +8.2% | +17.6% | +36.4% |
| LGND | SELL · 10b5-1 | 2026-04-01 | 2026-04-02 | $202.23 | $94K | +12.8% | +14.4% | +56.4% |
| LGND | SELL | 2026-03-02 | 2026-03-04 | $200.50 | $94K | +0.7% | -1.4% | +12.6% |
| LGND | SELL | 2026-02-02 | 2026-02-04 | $195.91 | $91K | -4.5% | +2.9% | +18.3% |
| LGND | SELL | 2026-01-02 | 2026-01-06 | $189.58 | $89K | -2.3% | -2.9% | +3.1% |
| LGND | SELL · 10b5-1 | 2025-12-01 | 2025-12-03 | $195.84 | $91K | +0.1% | -1.4% | +6.0% |
| LGND | SELL · 10b5-1 | 2025-11-03 | 2025-11-05 | $191.05 | $89K | +2.7% | -5.7% | +1.4% |
| LGND | SELL · 10b5-1 | 2025-10-01 | 2025-10-03 | $179.45 | $84K | +0.7% | +5.1% | +4.5% |
| LGND | SELL · 10b5-1 | 2025-09-02 | 2025-09-04 | $162.26 | $76K | -1.0% | +8.8% | +15.0% |
| LGND | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $131.88 | $123K | +12.7% | +25.1% | +42.6% |
| LGND | SELL · 10b5-1 | 2025-07-10 | 2025-07-11 | $125.00 | $117K | +12.9% | +21.8% | +51.1% |
| LGND | SELL | 2023-05-16 | 2023-05-18 | $77.20 | $686K | -9.0% | +0.4% | -13.2% |
| LGND | SELL | 2023-05-08 | 2023-05-10 | $76.54 | $936K | -1.7% | -3.7% | -12.4% |
| LGND | SELL | 2022-02-28 | 2022-03-01 | $102.62 | $186K | +5.3% | +15.0% | -9.1% |
| NTEC | BUY | 2019-08-23 | 2019-08-27 | $0.46 | $46K | +53.0% | +17.1% | -16.9% |
| LGND | SELL | 2019-05-14 | 2019-05-14 | $112.92 | $282K | +0.6% | +1.0% | -19.3% |
| LGND | SELL | 2018-10-01 | 2018-10-02 | $275.04 | $688K | -24.3% | -36.0% | -49.3% |
| LGND | SELL | 2018-07-02 | 2018-07-03 | $207.48 | $519K | +2.7% | +4.8% | +27.2% |
| LGND | SELL | 2018-04-02 | 2018-04-03 | $160.43 | $401K | +5.9% | -3.6% | +35.0% |
| LGND | SELL | 2018-01-10 | 2018-01-11 | $145.00 | $363K | +10.6% | +2.9% | +11.6% |
| LGND | SELL | 2017-11-16 | 2017-11-17 | $141.71 | $709K | -3.1% | +0.8% | +15.6% |
| LGND | SELL | 2016-09-07 | 2016-09-09 | $115.00 | $115K | +5.8% | -8.1% | -6.2% |
| LGND | SELL | 2016-09-01 | 2016-09-06 | $105.54 | $267K | +5.0% | -10.5% | -3.2% |
| LGND | SELL | 2016-08-01 | 2016-08-02 | $137.57 | $138K | -14.2% | -19.4% | -27.9% |
| LGND | SELL | 2016-07-01 | 2016-07-05 | $121.40 | $121K | +3.0% | +8.3% | -16.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.